... cells that dramatically alter their fate," said Deepak Srivastava, Director of Cardiovascular and Stem Cell Research, Gladstone Institutes. "We are thrilled to be part of the Fluidigm C1 Single-Cell Auto Prep System's Early Access Program and look ...
http://www.businesswire.com/news/topix/20130102005229/en
http://www.businesswire.com/news/topix/20130102005229/en
No comments:
Post a Comment